Combined oral contraceptives are the most convenient and accepted method of hormonal contraception. Nevertheless, the medical community and consumers constantly demand innovation, additional benefits during use and lower hormonal load despite the high safety profile of available products. At the Ernst Schering Research Foundation Workshop 52, new perspectives and mechanisms for tissue-selective, estrogen-free contraception were discussed. The aim of the workshop was to bring together experts in the field of molecular and pharmacodynamic action of progestins with clinicians and medical experts to discuss potential medical endpoints, physiological reactions and (bio)marker useful describing the tissue selectivity and the contraceptive action of new progestins in different target organs. A major factor for successful realization of these new concepts is a deeper understanding of local pharmacological responses to progestins in general and to new progestins in particular.
- Format: Kindle Edition
- File Size: 3260 KB
- Print Length: 266 pages
- Publisher: Springer Berlin Heidelberg; 1 edition (19 Jan. 2007)
- Sold by: Amazon Media EU S.à r.l.
- Language: English
- ASIN: B000PY3YOU
- Text-to-Speech: Enabled
- X-Ray: Not Enabled
- Word Wise: Not Enabled
- Enhanced Typesetting: Not Enabled
=-=-=-=-=-=-=-Material Connection Disclosure=-=-=-=-=-=-=
You should assume that the writer of this article has an affiliate relationship and/or another material connection to the providers of goods and services mentioned in this message and may be compensated when you purchase from a provider. You should always perform due diligence before buying goods or services from anyone via the Internet or offline.